Abbas Kashani, MD
Otolaryngology/Facial Plastic Surgery · Manteca, CANPI 1649237884
Payments from drug & device makers
What this record shows
Medical Device Business Services, Inc. accounts for 63.2% of it on its own, with 3 other manufacturers making up the rest. 2022 is the largest year on record at $305, 2.6 times the $119 reported in 2019. That places this record below the midpoint for otolaryngology/facial plastic surgery clinicians in CA, where the typical reported total is $1,073.
Across 8 payments — averaging $57.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$290
- Intersect ENT, Inc.$119
- AbbVie$35
- Stryker$15
What the payments were for
- Travel & lodging$24653%
- Food & beverage$21447%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 4 | $290 |
| Intersect ENT, Inc. | 1 | $119 |
| AbbVie | 2 | $35 |
| Stryker | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SINUVA$119
How this compares
$459 in reported general payments places this provider in the 35th percentile of 102 otolaryngology/facial plastic surgery providers in California.
See all otolaryngology/facial plastic surgery providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort | 48 | $2,302 |
| CefuroximeCefuroxime Axetil | 62 | $972 |
| Clotrimazole | 15 | $453 |
| Methylprednisolone | 59 | $308 |
| Azithromycin | 81 | $305 |
| Prednisone | 70 | $134 |
| Alprazolam | 11 | $23 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology/facial plastic surgery in Manteca
- Sarmela SunderLancaster$85K
- Vasu DiviStanford$51K
- Jen ChowArcadia$26K
- Ryan CasserlyMonterey$23K
- Ritvik MehtaCarlsbad$13K
- Alexis FurzeNewport Beach$12K
- Jahangir SharifiLos Angeles$12K
- Henry NguyenRancho Cucamonga$11K
- Paul NassifBeverly Hills$10K
- Babak AzizzadehBeverly Hills$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.